Dracen Announces DRP-104 (sirpiglenastat) Presentation at ASCO 2021
03 Jun 2021 //
PRWEB
Dracen Announces Clinical Collaboration with Merck
08 Mar 2021 //
PRWEB
Dracen DRP-104 Granted U.S. FDA Fast Track Designation for the treatment
27 Oct 2020 //
PRWEB
Dracen Pharma Announces the Initiation of First-in-human Study of DRP-104
25 Sep 2020 //
PRWEB
DRACEN ANNOUNCES TWO DRP-104 PRESENTATIONS AT AACR
05 Apr 2020 //
DRACENPHARMA